TIZANIDINE HYDROCHLORIDE
NDC 60760-892, tizanidine hydrochloride, capsule, from ST. MARY'S MEDICAL PARK PHARMACY.
- Product NDC
- 60760-892
- Status
- Listed
- Labeler
- ST. MARY'S MEDICAL PARK PHARMACY
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210267
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60760-892 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIZANIDINE HYDROCHLORIDE6 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60760-892-30 | 60760089230 | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-892-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4009c6cb-c183-2165-e063-6294a90aed78
Use it
Look up 60760-892 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60760-892 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60760-892. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.